As expected, the results demonstrated that the LINC00337 knockdown triggered reductions in tumor volume and weight in mice (p < 0.05, Figures 6A–C), ultimately suggesting that LINC00337 knockdown reduces tumorigenicity of CD44+/CD24low/−SFCs. This evidence concerns the gene CD44 and neoplasm.